User profiles for Pavan Reddy
Pavan ReddyProfessor Verified email at bcm.edu Cited by 31987 |
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
…, S Pennathur, M Van Den Brink, P Reddy - Nature …, 2016 - nature.com
The effect of alterations in intestinal microbiota on microbial metabolites and on disease
processes such as graft-versus-host disease (GVHD) is not known. Here we carried out an …
processes such as graft-versus-host disease (GVHD) is not known. Here we carried out an …
Acute graft-versus-host disease does not require alloantigen expression on host epithelium
Alloantigen expression on host antigen-presenting cells (APCs) is essential to initiate graft-versus-host
disease (GvHD); therefore, alloantigen expression on host target epithelium is …
disease (GvHD); therefore, alloantigen expression on host target epithelium is …
[HTML][HTML] Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors
Purpose Thirty percent to 90% of cancer survivors report impaired sleep quality post-treatment,
which can be severe enough to increase morbidity and mortality. Lifestyle interventions, …
which can be severe enough to increase morbidity and mortality. Lifestyle interventions, …
Graft-versus-host disease
Haemopoietic-cell transplantation (HCT) is an intensive therapy used to treat high-risk
haematological malignant disorders and other life-threatening haematological and genetic …
haematological malignant disorders and other life-threatening haematological and genetic …
[HTML][HTML] Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
…, HL Gomez Moreno, PS Reddy… - … England Journal of …, 2018 - Mass Medical Soc
Background The recurrence score based on the 21-gene breast cancer assay predicts
chemotherapy benefit if it is high and a low risk of recurrence in the absence of chemotherapy if it …
chemotherapy benefit if it is high and a low risk of recurrence in the absence of chemotherapy if it …
[HTML][HTML] Prospective validation of a 21-gene expression assay in breast cancer
…, HL Gomez Moreno, PS Reddy… - … England Journal of …, 2015 - Mass Medical Soc
Background Prior studies with the use of a prospective–retrospective design including
archival tumor samples have shown that gene-expression assays provide clinically useful …
archival tumor samples have shown that gene-expression assays provide clinically useful …
[HTML][HTML] First-line nivolumab plus ipilimumab in advanced non–small-cell lung cancer (CheckMate 568): outcomes by programmed death ligand 1 and tumor …
…, J Brahmer, I Rabinowitz, PS Reddy… - Journal of Clinical …, 2019 - ncbi.nlm.nih.gov
PURPOSE CheckMate 568 is an open-label phase II trial that evaluated the efficacy and safety
of nivolumab plus low-dose ipilimumab as first-line treatment of advanced/metastatic non…
of nivolumab plus low-dose ipilimumab as first-line treatment of advanced/metastatic non…
Pathophysiology of graft-versus-host disease
JLM Ferrara, P Reddy - Seminars in hematology, 2006 - Elsevier
Complications of allogeneic hematopoietic stem cell transplantation (HSCT) remain barriers
to its wider application for a variety of diseases. Graft-versus-host disease (GVHD) is the …
to its wider application for a variety of diseases. Graft-versus-host disease (GVHD) is the …
[HTML][HTML] Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer
…, HL Gomez Moreno, PS Reddy… - New England journal …, 2019 - Mass Medical Soc
Background The use of adjuvant chemotherapy in patients with breast cancer may be guided
by clinicopathological factors and a score based on a 21-gene assay to determine the risk …
by clinicopathological factors and a score based on a 21-gene assay to determine the risk …
A biomarker panel for acute graft-versus-host disease
…, D Jones, J Whitfield, P Reddy… - Blood, The Journal …, 2009 - ashpublications.org
No validated biomarkers exist for acute graft-versus-host disease (GVHD). We screened
plasma with antibody microarrays for 120 proteins in a discovery set of 42 patients who …
plasma with antibody microarrays for 120 proteins in a discovery set of 42 patients who …